Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension
暂无分享,去创建一个
Yanfei Qi | Joseph Francis | Henry Daniell | M. Raizada | J. Francis | H. Daniell | Y. Qi | Kwang-Chul Kwon | M. Katovich | Qiuhong Li | Vinayak Shenoy | Kwang-Chul Kwon | Anandharajan Rathinasabapathy | Shina Lin | Guiying Jin | Chunjuan Song | Pollob Shil | Anand Nair | Qiuhong Li | Michael J. Katovich | Mohan K. Raizada | Chunjuan Song | V. Shenoy | A. Rathinasabapathy | A. Nair | Shina Lin | Guiying Jin | Pollob Shil | Anand R. Nair
[1] Nikolaj Blom,et al. Prediction of proprotein convertase cleavage sites. , 2004, Protein engineering, design & selection : PEDS.
[2] F. Walther,et al. Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[3] D. Ganten,et al. Converting enzyme determines plasma clearance of angiotensin-(1-7). , 1998, Hypertension.
[4] Henry Daniell,et al. Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells. , 2013, Plant biotechnology journal.
[5] Tracey A Ruhlman,et al. The Role of Heterologous Chloroplast Sequence Elements in Transgene Integration and Expression1[W][OA] , 2010, Plant Physiology.
[6] H. Daniell,et al. Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals , 2001, Nature Biotechnology.
[7] H. Daniell,et al. Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function , 2009, BMC biotechnology.
[8] B. Morton,et al. Chloroplast DNA codon use: Evidence for selection at the psb A locus based on tRNA availability , 1993, Journal of Molecular Evolution.
[9] H. Daniell,et al. A protocol for expression of foreign genes in chloroplasts , 2008, Nature Protocols.
[10] E. G. Erdös,et al. Angiotensin I converting enzyme. , 1975, Circulation research.
[11] Oscar N. Ruiz,et al. Metallothionein expression in chloroplasts enhances mercury accumulation and phytoremediation capability. , 2011, Plant biotechnology journal.
[12] R. Gao,et al. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections , 2014, Nature Communications.
[13] H. Daniell,et al. Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice , 2010, Proceedings of the National Academy of Sciences.
[14] H. Daniell,et al. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. , 2013, Advanced drug delivery reviews.
[15] M. Raizada,et al. Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer , 2009, Hypertension.
[16] Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension. , 2015, Hypertension.
[17] N. Morrell,et al. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. , 1995, The Journal of clinical investigation.
[18] J. Mocco,et al. Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. , 2013, American journal of respiratory and critical care medicine.
[19] J. Grobe,et al. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. , 2006, American journal of physiology. Heart and circulatory physiology.
[20] D. Lalloo,et al. Oral cholera vaccines: use in clinical practice. , 2006, The Lancet. Infectious diseases.
[21] Marc A. Simon,et al. Assessment and treatment of right ventricular failure , 2013, Nature Reviews Cardiology.
[22] M. Raizada,et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). , 2007, American journal of physiology. Heart and circulatory physiology.
[23] C. Czerkinsky,et al. Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit , 2009, Scandinavian journal of immunology.
[24] T. Whittall,et al. Oral tolerization with peptide 336–351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease , 2004, Clinical and experimental immunology.
[25] L. Burrell,et al. Angiotensin-(1–7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy , 2010, Clinical science.
[26] Thomas Walther,et al. Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Raizada,et al. Targeting the Vasoprotective Axis of the Renin-Angiotensin System: A Novel Strategic Approach to Pulmonary Hypertensive Therapy , 2010, Current hypertension reports.
[28] H. Ghofrani,et al. Mechanisms of disease: pulmonary arterial hypertension , 2011, Nature Reviews Cardiology.
[29] Neha Kohli,et al. Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] K. Robison,et al. A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 , 2000, Circulation research.
[31] J. Holmgren,et al. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[32] Ming Zhang,et al. The Changes of Serum Angiotensin-Converting Enzyme 2 in Patients with Pulmonary Arterial Hypertension due to Congenital Heart Disease , 2013, Cardiology.
[33] S. Karlin,et al. What drives codon choices in human genes? , 1996, Journal of molecular biology.
[34] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[35] M. Raizada,et al. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. , 2010, American journal of respiratory and critical care medicine.
[36] H. Daniell,et al. Field production and functional evaluation of chloroplast-derived interferon-alpha2b. , 2007, Plant biotechnology journal.
[37] J. Penninger,et al. Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy , 2009, Diabetes.
[38] Z. Otwinowski,et al. The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid. , 1995, Journal of molecular biology.
[39] Nigel M. Hooper,et al. A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.
[40] A. Loeckinger,et al. Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia. , 2012, Wilderness & environmental medicine.
[41] N. Morrell,et al. Chloroquine Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Lysosomal Bone Morphogenetic Protein Type II Receptor Degradation , 2013, Circulation research.
[42] Tracey A Ruhlman,et al. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice. , 2007, Plant biotechnology journal.
[43] Henry Daniell,et al. Low Cost Tuberculosis Vaccine Antigens in Capsules: Expression in Chloroplasts, Bio-Encapsulation, Stability and Functional Evaluation In Vitro , 2013, PloS one.
[44] D. Diz,et al. Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues. , 2000, American journal of physiology. Renal physiology.
[45] M. Raizada,et al. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. , 2009, American journal of respiratory and critical care medicine.
[46] E. Michelakis,et al. Pulmonary Arterial Hypertension: Challenges in Translational Research and a Vision for Change , 2013, Science Translational Medicine.
[47] H. Daniell,et al. Plant-made vaccine antigens and biopharmaceuticals , 2009, Trends in Plant Science.
[48] J. Wilson,et al. Surface area of the small intestine in man. , 1967, Gut.
[49] M. Wood,et al. From gut to brain: bioencapsulated therapeutic protein reduces amyloid load upon oral delivery. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[50] M. Humbert,et al. Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[51] H. Daniell,et al. Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. , 2011, Plant biotechnology journal.
[52] M. Humbert,et al. Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.
[53] J. Moss,et al. Uptake and metabolism of exogenous gangliosides by cultured cells: effect of choleragen on the turnover of GM1. , 1983, Journal of lipid research.
[54] B. Uhal,et al. Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[55] A. Mehta,et al. Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. , 2011, Blood.
[56] J. Penninger,et al. Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2 , 2011, Hypertension.
[57] R. Iliescu,et al. Expression of an angiotensin-( 1 – 7 )-producing fusion protein produces cardioprotective effects in rats , 2004 .
[58] G. Chisolm,et al. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. , 1996, Hypertension.
[59] H. Daniell. Transgene containment by maternal inheritance: Effective or elusive? , 2007, Proceedings of the National Academy of Sciences.